{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Richland",
      "address_1": "199 Interstate Dr Ste N",
      "reason_for_recall": "CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures",
      "address_2": "",
      "product_quantity": "795 bottles",
      "code_info": "LOT # 29401501, EXP 10/17",
      "center_classification_date": "20161129",
      "distribution_pattern": "Nationwide",
      "state": "MS",
      "product_description": "Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains:  Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10",
      "report_date": "20161207",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Burel Pharmaceuticals Inc",
      "recall_number": "D-0160-2017",
      "initial_firm_notification": "E-Mail",
      "product_type": "Drugs",
      "event_id": "75566",
      "termination_date": "20170814",
      "more_code_info": "",
      "recall_initiation_date": "20161024",
      "postal_code": "39218-9433",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}